The Health-eBrain Study launches Phase II to investigate the impact of Alzheimer's caregiving on brain and behavioral health. An international cohort of caregivers will use a mobile app to assess their cognitive function over 12 weeks, tracking stress levels, sleep, mood, and self-evaluation of memory.
The BrightFocus Foundation has awarded nearly $5 million in vision research grants to five scientists studying macular degeneration and glaucoma. The grants, named after prominent leaders in the field, will support innovative research projects aimed at understanding and preventing these diseases.
Researchers have discovered a potential link between Parkinson's treatment and protection against age-related macular degeneration (AMD), the most common form of blindness. The study suggests that patients taking L-DOPA as Parkinson's treatment may be less likely to develop AMD, with delayed or prevented disease progression.
BrightFocus Foundation has awarded $11 million in research grants to 58 scientists worldwide. The grants focus on treatments for age-related diseases such as Alzheimer's, glaucoma, and macular degeneration, with a emphasis on early detection, disease progression, and potential interventions.
The BrightFocus Foundation has honored five outstanding scientists in the fields of macular degeneration and glaucoma. Researchers from California, Florida, Maryland, Michigan, and Texas received $3.5 million in grant awards to study new treatments for these eye diseases.
The BrightFocus Foundation has awarded $7.2 million in grants to 53 scientists conducting research on Alzheimer's, glaucoma, and macular degeneration. The funded projects focus on imaging technology, gene therapy, and cell regeneration to better understand disease development and potential new therapies.
The American Health Assistance Foundation has awarded grants to scientists worldwide studying the link between Alzheimer's disease and glaucoma, as well as protective mechanisms for eye cells. Researchers are also developing new treatments for macular degeneration, a condition causing vision loss in older adults.
The American Health Assistance Foundation (AHAF) has awarded 22 new research grants to scientists studying innovative approaches to combat Alzheimer's disease, including repurposing existing drugs and examining the link between diabetes and cognitive decline.
The CATT study found that Avastin and Lucentis were similarly effective in maintaining vision for AMD patients, with two-thirds of patients retaining 20/40 or better vision after two years. However, the study highlights the need for further research on dry form AMD and a stronger national commitment to funding eye research.